What question did this study set out to answer?

To assess clinical features and evaluate the therapeutic outcomes of early corticosteroid administration in children hospitalized with Mycoplasma pneumoniae pneumonia.

April 4, 2023Frontiers in Cellular and Infection MicrobiologyOpen Access

Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia

View Full Paper

Ask AI

Bookmark

To assess clinical features and evaluate the therapeutic outcomes of early corticosteroid administration in children hospitalized with Mycoplasma pneumoniae pneumonia.
Analyzed clinical and imaging records of N=210 pediatric patients with confirmed Mycoplasma pneumoniae pneumonia who had pulmonary infiltrates within 5 days and presentation within 10 days of onset.
Classified patients by chest imaging into Group A (bronchiolitis-associated lesions or ground-glass opacities, n=59) and Group B (segmental or lobar consolidation, n=151).
Assessed methylprednisolone administration (starting between days 5 and 10 of onset, peak dose ≥2 mg/kg/day, with high-dose regimens for severe lesions) and measured radiographic outcomes at 3 months.
Group A patients exhibited significantly more allergy histories, hypoxemia, wheezing, and wet rales than Group B patients.
Methylprednisolone was initiated within 5 to 10 days of disease onset (predominantly days 6 to 7) at doses ≥2 mg/kg/day, including high-dose therapy in 8 Group A patients with diffuse bronchiolitis and 20 Group B patients with lobar consolidation.
At 3 months, 3 patients in Group A had persistent ground-glass opacities, while 7 patients in Group B exhibited incomplete lesion resolution, with 5 multi-lobar consolidation cases developing slight bronchiolitis obliterans.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study shows early corticosteroid therapy improves outcomes in pediatric Mycoplasma pneumoniae pneumonia, indicating initiation within six to seven days limits long-term lung sequelae.

Cite This Study

Liu et al. (2023) studied this question.

synapsesocial.com/papers/6a0340fe59ea043e4c9e49f8 https://doi.org/10.3389/fcimb.2023.1135228

View Full Paper

Ask AI

Bookmark

Implication

Observational study shows early corticosteroid therapy improves outcomes in pediatric Mycoplasma pneumoniae pneumonia, indicating initiation within six to seven days limits long-term lung sequelae.

Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia

Key Points

Discussion

Implication

Cite This Study

Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider